Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.07% Nasdaq Down 0.83%
Streaming
Ticker Tape: On

More On 009420.KS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

HanAll Biopharma Co., Ltd. (009420.KS)

-KSE
4,495.00 Down 45.00(0.99%) 2:00AM EDT
Get the big picture on all your investments.
Prev Close:4,540.00
Open:4,550.00
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:4,490.00 - 4,610.00
52wk Range:3,715.00 - 8,390.00
Volume:134,836
Avg Vol (3m):215,583
Market Cap:182.40B
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in KRW.

Headlines

  • No Headlines available for 009420.KS at this time.

Reports

  • No Reports available for 009420.KS at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

HanAll BioPharma Co., Ltd., a biopharmaceutical company, engages in the research and development of biopharmaceutical products for the treatment of oncology, fibrotic, infectious, ophthalmology, immunology, endocrinology, and cardiovascular diseas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback